Evidence map›Paper›PMID 37079513›Full record

ArticlePloS one2023

Structural equation modeling (SEM) of kidney function markers and longitudinal CVD risk assessment.

Ryosuke Fujii, Roberto Melotti, Martin Gögele, Laura Barin, Dariush Ghasemi-Semeskandeh, Giulia Barbieri, Peter P Pramstaller, Cristian Pattaro

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Ryosuke FujiiInstitute for Biomedicine (Affiliated to the University of Lübeck), Eurac Research, Bolzano, Bozen, Italy.ORCID 0000-0003-1730-2059
Roberto MelottiInstitute for Biomedicine (Affiliated to the University of Lübeck), Eurac Research, Bolzano, Bozen, Italy.ORCID 0000-0003-4115-317X
Martin GögeleInstitute for Biomedicine (Affiliated to the University of Lübeck), Eurac Research, Bolzano, Bozen, Italy.ORCID 0000-0003-4785-4348
Laura BarinInstitute for Biomedicine (Affiliated to the University of Lübeck), Eurac Research, Bolzano, Bozen, Italy.
Dariush Ghasemi-SemeskandehInstitute for Biomedicine (Affiliated to the University of Lübeck), Eurac Research, Bolzano, Bozen, Italy.
Giulia BarbieriInstitute for Biomedicine (Affiliated to the University of Lübeck), Eurac Research, Bolzano, Bozen, Italy.
Peter P PramstallerInstitute for Biomedicine (Affiliated to the University of Lübeck), Eurac Research, Bolzano, Bozen, Italy.ORCID 0000-0002-9831-8302
Cristian PattaroInstitute for Biomedicine (Affiliated to the University of Lübeck), Eurac Research, Bolzano, Bozen, Italy.
Eurac Research · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lower kidney function is known to enhance cardiovascular disease (CVD) risk. It is unclear which estimated glomerular filtration rate (eGFR) equation best predict an increased CVD risk and if prediction can be improved by integration of multiple kidney function markers. We performed structural equation modeling (SEM) of kidney markers and compared the performance of the resulting pooled indexes with established eGFR equations to predict CVD risk in a 10-year longitudinal population-based design. We split the study sample into a set of participants with only baseline data (n = 647; model-building set) and a set with longitudinal data (n = 670; longitudinal set). In the model-building set, we fitted five SEM models based on serum creatinine or creatinine-based eGFR (eGFRcre), cystatin C or cystatin-based eGFR (eGFRcys), uric acid (UA), and blood urea nitrogen (BUN). In the longitudinal set, 10-year incident CVD risk was defined as a Framingham risk score (FRS)>5% and a pooled cohort equation (PCE)>5%. Predictive performances of the different kidney function indexes were compared using the C-statistic and the DeLong test. In the longitudinal set, a SEM-based estimate of latent kidney function based on eGFRcre, eGFRcys, UA, and BUN showed better prediction performance for both FRS>5% (C-statistic: 0.70; 95% CI: 0.65-0.74) and PCE>5% (C-statistic: 0.75; 95%CI: 0.71-0.79) than other SEM models and different eGFR formulas (DeLong test p-values<3.21×10-6 for FRS>5% and <1.49×10-9 for PCE>5%, respectively). However, the new derived marker could not outperform eGFRcys (DeLong test p-values = 0.88 for FRS>5% and 0.20 for PCE>5%, respectively). SEM is a promising approach to identify latent kidney function signatures. However, for incident CVD risk prediction, eGFRcys could still be preferrable given its simpler derivation.

Indexed as

Cardiovascular DiseasesRenal Insufficiency, ChronicBiomarkersCreatinineGlomerular Filtration RateHumansKidneyKidney Function TestsLatent Class AnalysisRisk AssessmentBiomarkersCreatinine

Identifiers

PMID37079513
PMCPMC10118200
OpenAlexW4366463531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.